Post-COVID-19 Symptoms in Adults with Asthma-Systematic Review

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 Aug 26

PMID 37626764

Authors

Marek Kaszuba

Natalia Madej

Rafal Pilinski

Agnieszka Sliwka

Affiliations

Soon will be listed here.

Abstract

Background: Research on the longer-term sequelae of COVID-19 in patients with asthma is limited.

Objective: To assess the frequency and severity of long-term symptoms of COVID-19 in the population of asthma patients.

Methods: A systematic review of the published literature was conducted in accordance with the recommendations of the PRISMA statement. EMBASE, MEDLINE/PubMed, Web of Science, CINAHL, and Scopus Scholar were searched for terms related to asthma and post or long COVID-19, and for systematic reviews related to specific questions within our review, up to June 2022.

Results: Data from 9 references publications included in the review were extracted. A total of 1466 adult asthmatic patients with COVID-19 infection were described in all the publications mentioned above. Of the long-term symptoms reported after COVID-19, patients indicated: lower respiratory symptoms, fatigue, cognitive symptoms, psychological problems, and other such as skin rashes, gastrointestinal disorders, tachycardia, palpitations, ocular disorders, ageusia/hypogeusia, anosmia/hyposmia, and poor sleep quality. These symptoms in similar intensity were observed in the comparison groups without a diagnosis of asthma.

Conclusions: The published data neither confirm nor deny that long-term COVID-19 symptoms in patients with asthma diagnosis are different in strength and frequency from patients without asthma diagnosis. To indicate associations between asthma and COVID-19 infection and severity, as well as the frequency of long-term symptoms of COVID-19, more longitudinal research is needed in chronic asthma patients with different phenotypes, intensity of treatment, and degree of asthma control.

Citing Articles

Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.

Calcaterra V, Zanelli S, Foppiani A, Verduci E, Benatti B, Bollina R Diseases. 2024; 12(5).

PMID: 38785750 PMC: 11120262. DOI: 10.3390/diseases12050095.

Symptoms, Mental Health, and Quality of Life Among Patients After COVID-19 Infection: A Cross-sectional Study in Vietnam.

Thanh H, Minh D, Thu H, Quang D J Prev Med Public Health. 2024; 57(2):128-137.

PMID: 38419549 PMC: 10999303. DOI: 10.3961/jpmph.23.511.

Assessment of Some Risk Factors and Biological Predictors in the Post COVID-19 Syndrome in Asthmatic Patients.

Melinte O, Robu Popa D, Dobrin M, Cernomaz A, Grigorescu C, Nemes A J Pers Med. 2024; 14(1).

PMID: 38248722 PMC: 10820086. DOI: 10.3390/jpm14010021.

References

Greenhalgh T, Knight M, ACourt C, Buxton M, Husain L . Management of post-acute covid-19 in primary care. BMJ. 2020; 370:m3026. DOI: 10.1136/bmj.m3026. View

Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O . Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021; 51(9):1107-1120. PMC: 8444748. DOI: 10.1111/cea.13997. View

Martimbianco A, Pacheco R, Maria Bagattini A, Riera R . Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021; 75(10):e14357. PMC: 8236920. DOI: 10.1111/ijcp.14357. View

Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W . The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. J Virol. 2020; 95(1). PMC: 7737752. DOI: 10.1128/JVI.01648-20. View

Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2020; 27(2):258-263. PMC: 7534895. DOI: 10.1016/j.cmi.2020.09.052. View

Ferastraoaru D, Hudes G, Jerschow E, Jariwala S, Karagic M, de Vos G . Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. J Allergy Clin Immunol Pract. 2021; 9(3):1152-1162.e3. PMC: 7826039. DOI: 10.1016/j.jaip.2020.12.045. View

Peters M, Fahy J . Erratum: COVID-19-related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids. Am J Respir Crit Care Med. 2020; 202(12):1744-1746. PMC: 7737596. DOI: 10.1164/rccm.v202erratum7. View

Kermani N, Song W, Badi Y, Versi A, Guo Y, Sun K . Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma. Respir Res. 2021; 22(1):10. PMC: 7788167. DOI: 10.1186/s12931-020-01605-8. View

Nassoro D, Mujwahuzi L, Mwakyula I, Possi M, Lyantagaye S . Asthma and COVID-19: Emphasis on Adequate Asthma Control. Can Respir J. 2021; 2021:9621572. PMC: 8397565. DOI: 10.1155/2021/9621572. View

10.

Akbarialiabad H, Taghrir M, Abdollahi A, Ghahramani N, Kumar M, Paydar S . Long COVID, a comprehensive systematic scoping review. Infection. 2021; 49(6):1163-1186. PMC: 8317481. DOI: 10.1007/s15010-021-01666-x. View

11.

Munker D, Veit T, Barton J, Mertsch P, Mummler C, Osterman A . Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection. 2021; 50(1):157-168. PMC: 8318328. DOI: 10.1007/s15010-021-01669-8. View

12.

Eggert L, He Z, Collins W, Lee A, Dhondalay G, Jiang S . Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19. Allergy. 2021; 77(1):173-185. PMC: 8222896. DOI: 10.1111/all.14972. View

13.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

14.

Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo Jr C, Liang L . Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020; 146(2):327-329.e4. PMC: 7423602. DOI: 10.1016/j.jaci.2020.06.001. View

15.

Lee B, Lewis G, Agyei-Manu E, Atkins N, Bhattacharyya U, Dozier M . Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis. Eur Respir Rev. 2022; 31(166). PMC: 9724896. DOI: 10.1183/16000617.0066-2022. View

16.

Luis Izquierdo J, Almonacid C, Gonzalez Y, Del Rio-Bermudez C, Ancochea J, Cardenas R . The impact of COVID-19 on patients with asthma. Eur Respir J. 2020; 57(3). PMC: 7651839. DOI: 10.1183/13993003.03142-2020. View

17.

Mahdavinia M, Foster K, Jauregui E, Moore D, Adnan D, Andy-Nweye A . Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract. 2020; 8(7):2388-2391. PMC: 7224651. DOI: 10.1016/j.jaip.2020.05.006. View

18.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

19.

Faverio P, Luppi F, Rebora P, Busnelli S, Stainer A, Catalano M . Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study. Respiration. 2021; 100(11):1078-1087. PMC: 8450855. DOI: 10.1159/000518141. View

20.

Choi Y, Park J, Lee H, Suh J, Song J, Byun M . Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2020; 57(3). PMC: 7518077. DOI: 10.1183/13993003.02226-2020. View